Knightscope Receives Nasdaq Deficiency Letter on $1.00 Bid Price, 180 Days to May 3, 2027
KSCP sits 19% above its 52-week low of $0.402 on elevated volume (2.6× avg).
Summary
Knightscope has received a Nasdaq notice that its stock traded below the $1.00 minimum bid for 30 consecutive business days, leaving it until May 3, 2027 to regain compliance or potentially face delisting.
Key Events · Legal and Risk Events · KSCP
-
Nasdaq Minimum Bid Deficiency Notice
On November 4, 2026, Knightscope received a Nasdaq Staff deficiency letter after its Class A common stock closed below the $1.00 minimum bid price for the last 30 consecutive business days under Listing Rule 5550(a)(2).
-
180-Day Cure Window to May 3, 2027
The company has until May 3, 2027 to close at $1.00 or more for a minimum of ten consecutive business days; with the stock at $0.48, that requires roughly a doubling of the share price.
-
Reverse Split Likely Path to Cure
A second 180-day compliance period is available only if Knightscope meets the market value of publicly held shares and other initial listing standards, and it would require written notice of intent to cure by reverse stock split if necessary.
-
Delisting Risk If Not Cured
If compliance is not regained and no additional period applies, Nasdaq will notify the company that its stock is subject to delisting; Knightscope may appeal to a Nasdaq Hearings Panel, but there is no assurance an appeal would succeed.
Analysis · KSCP · Manufacturing
A Nasdaq deficiency notice has landed after Knightscope's Class A stock closed below $1.00 for 30 straight business days. To cure, the shares must close at $1.00 or higher for at least ten consecutive business days by May 3, 2027; a second 180-day window opens only if the company meets the other Capital Market listing standards and signals a reverse split if needed. With the stock at $0.48, regaining compliance organically would take roughly a doubling of the share price, making a reverse split the realistic path — and that would come on top of a company already burning cash with a going concern warning and an expanded $35M ATM. Should the deficiency go uncured, Nasdaq will issue a delisting determination, which the company can appeal to a Nasdaq Hearings Panel, though there is no assurance of success.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KSCP was trading at $0.48 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $11.2M. The 52-week trading range was $0.40 to $5.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.